Biosergen AS

Research Biosergen AS (BIOSGN) on Bullrun: market cap SEK 10.94M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBIOSGN
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 10.94M
• Financial periodQ4 2025
• Net income-SEK 12.46M
• Free cash flow-SEK 7.75M

Valuation Snapshot

latest market cap is SEK 10.94M.

About Biosergen AS

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.

Frequently asked questions

What is Biosergen AS's market cap?

Biosergen AS's market capitalization is SEK 10.94M.

What does Biosergen AS do?

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients.